(Q33968480)

English

Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Friedreich ataxia

1 reference

based on heuristic

inferred from title

Christian Rummey

object named as

Christian Rummey

3

0 references

2

object named as

Susan L Perlman

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Thomas Meier

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Nicholas J Coppard

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

David R Lynch

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

22 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

259

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

284-291

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

The natural history of degenerative ataxia: a retrospective study in 466 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Clinical and genetic abnormalities in patients with Friedreich's ataxia

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Diagnosis and treatment of Friedreich ataxia: a European perspective

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Idebenone in Friedreich's ataxia

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Clinical experience with high-dose idebenone in Friedreich ataxia

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Friedreich's ataxia: idebenone treatment in early stage patients

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Dysarthria in Friedreich's ataxia: a perceptual analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Clinical measures of dysarthria in Friedreich Ataxia.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

How is disease progress in Friedreich's ataxia best measured? A study of four rating scales.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

The International Cooperative Ataxia Rating Scale shows strong age-dependency in children.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Safety, Tolerability, and Pharmacokinetics of High-Dose Idebenone in Patients With Friedreich Ataxia

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6174-Y

21 January 2018

Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779958

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality in Friedreich ataxia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779958

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779958

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-011-6174-Y

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33968480&oldid=2196064657"